FGF21 and hepatocellular carcinoma: Higher FGF21 expression was correlated with more resistance to sorafenib treatment in HCC patients, and intra-tumoral FGF21 knockdown effectively inhibited tumor growth in sorafenib-resistant HCC animal models 94.